Biocon receives Europe approval for Rosuvastatin calcium tablets
Biocon has received its first generic formulation approval in Europe to launch Rosuvastatin calcium tablets in several European countries. The product will be produced in […]
Biocon
Biocon makes progress in oral insulin drug Tregopil
Biocon has made progress in phase-I clinical studies conducted in the US for insulin Tregopil and is looking at oral delivery of insulin. The company […]
Biocon acquires Acacia Lifesciences
Biocon has acquired a manufacturing unit of Acacia Lifesciences in Vizag for an undisclosed amount. The company has acquired business assets of the pharmaceutical manufacturing […]